Functionalized DMP-039 Hybrid Nanoparticle as a Novel mRNA Vector for Efficient Cancer Suicide Gene Therapy

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.21590
   PubMed Web of Science ®Google Scholar
• Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363–385. doi:10.3322/caac.21565
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–164. doi:10.3322/caac.21601
   PubMed Web of Science ®Google Scholar
• Ladabaum U, Dominitz JA, Kahi C, Schoen RE. Strategies for colorectal cancer screening. Gastroenterology. 2020;158(2):418–432. doi:10.1053/j.gastro.2019.06.043
   PubMed Web of Science ®Google Scholar
• Kaleta-Richter M, Kawczyk-Krupka A, Aebisher D, Bartusik-Aebisher D, Czuba Z, Cieślar G. The capability and potential of new forms of personalized colon cancer treatment: immunotherapy and photodynamic therapy. Photodiagnosis Photodyn Ther. 2019;25:253–258. doi:10.1016/j.pdpdt.2019.01.004
   PubMed Web of Science ®Google Scholar
• Luo C, Miao L, Zhao Y, et al. A novel cationic lipid with intrinsic antitumor activity to facilitate gene therapy of TRAIL DNA. Biomaterials. 2016;102:239–248. doi:10.1016/j.biomaterials.2016.06.030
   PubMed Web of Science ®Google Scholar
• Tauriello DVF, Palomo-Ponce S, Stork D, et al. TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis. Nature. 2018;554(7693):538–543. doi:10.1038/nature25492
   PubMed Web of Science ®Google Scholar
• Zhou M, Liu X, Li Z, Huang Q, Li F, Li CY. Caspase-3 regulates the migration, invasion and metastasis of colon cancer cells. Int J Cancer. 2018;143(4):921–930. doi:10.1002/ijc.31374
   PubMed Web of Science ®Google Scholar
• Chen EX, Jonker DJ, Loree JM, et al. Effect of combined immune checkpoint inhibition vs best supportive care alone in patients with advanced colorectal cancer: the Canadian cancer trials group co.26 study. JAMA Oncol. 2020;6(6):831–838. doi:10.1001/jamaoncol.2020.0910
   PubMed Web of Science ®Google Scholar
• Toor SM, Murshed K, Al-Dhaheri M, Khawar M, Abu Nada M, Elkord E. Immune checkpoints in circulating and tumor-infiltrating CD4(+) T cell subsets in colorectal cancer patients. Front Immunol. 2019;10:2936. doi:10.3389/fimmu.2019.02936
   PubMed Web of Science ®Google Scholar
• Liang Q, Monetti C, Shutova MV, et al. Linking a cell-division gene and a suicide gene to define and improve cell therapy safety. Nature. 2018;563(7733):701–704. doi:10.1038/s41586-018-0733-7
   PubMed Web of Science ®Google Scholar
• Kuo WY, Hwu L, Wu CY, Lee JS, Chang CW, Liu RS. STAT3/NF-κB-regulated lentiviral TK/GCV suicide gene therapy for cisplatin-resistant triple-negative breast cancer. Theranostics. 2017;7(3):647–663. doi:10.7150/thno.16827
   PubMedGoogle Scholar
• Chi X, Nguyen D, Pemberton JM, et al. The carboxyl-terminal sequence of bim enables bax activation and killing of unprimed cells. eLife. 2020;9:e44525. doi:10.7554/eLife.44525
   PubMed Web of Science ®Google Scholar
• Hildeman DA, Zhu Y, Mitchell TC, et al. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity. 2002;16(6):759–767. doi:10.1016/s1074-7613(02)00322-9
   PubMedGoogle Scholar
• Qian L, Van Laake LW, Huang Y, Liu S, Wendland MF, Srivastava D. miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J Exp Med. 2011;208(3):549–560. doi:10.1084/jem.20101547
   PubMed Web of Science ®Google Scholar
• Krishnamurthy B, Chee J, Jhala G, et al. BIM deficiency protects NOD mice from diabetes by diverting thymocytes to regulatory T cells. Diabetes. 2015;64(9):3229–3238. doi:10.2337/db14-1851
   PubMedGoogle Scholar
• Biswas SC, Shi Y, Vonsattel JP, Leung CL, Troy CM, Greene LA. Bim is elevated in Alzheimer’s disease neurons and is required for beta-amyloid-induced neuronal apoptosis. J Neurosci. 2007;27(4):893–900. doi:10.1523/jneurosci.3524-06.2007
   PubMedGoogle Scholar
• Lauer C, Brunner T, Corazza N. The proapoptotic Bcl-2 family member Bim plays a central role during the development of virus-induced hepatitis. J Immunol. 2012;188(2):916–922. doi:10.4049/jimmunol.1101864
   PubMedGoogle Scholar
• Lei S, Zhang X, Li J, et al. Current progress in messenger RNA-based gene therapy. J Biomed Nanotechnol. 2020;16(7):1018–1044. doi:10.1166/jbn.2020.2961
   PubMedGoogle Scholar
• Sahin U, Muik A, Derhovanessian E, et al. COVID-19 vaccine BNT162b1 elicits human antibody and T(H)1 T cell responses. Nature. 2020;586(7830):594–599. doi:10.1038/s41586-020-2814-7
   PubMed Web of Science ®Google Scholar
• Corbett KS, Flynn B, Foulds KE, et al. Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates. N Engl J Med. 2020;383(16):1544–1555. doi:10.1056/NEJMoa2024671
   PubMed Web of Science ®Google Scholar
• Yan H, Hu Y, Akk A, et al. Induction of WNT16 via peptide-mRNA nanoparticle-based delivery maintains cartilage homeostasis. Pharmaceutics. 2020;12(1):73. doi:10.3390/pharmaceutics12010073
   PubMed Web of Science ®Google Scholar
• An D, Frassetto A, Jacquinet E, et al. Long-term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia. EBioMedicine. 2019;45:519–528. doi:10.1016/j.ebiom.2019.07.003
   PubMedGoogle Scholar
• Feldman RA, Fuhr R, Smolenov I, et al. mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in Phase 1 randomized clinical trials. Vaccine. 2019;37(25):3326–3334. doi:10.1016/j.vaccine.2019.04.074
   PubMed Web of Science ®Google Scholar
• Corbett KS, Edwards DK, Leist SR, et al. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature. 2020;586(7830):567–571. doi:10.1038/s41586-020-2622-0
   PubMed Web of Science ®Google Scholar
• Monslow MA, Elbashir S, Sullivan NL, et al. Immunogenicity generated by mRNA vaccine encoding VZV gE antigen is comparable to adjuvanted subunit vaccine and better than live attenuated vaccine in nonhuman primates. Vaccine. 2020;38(36):5793–5802. doi:10.1016/j.vaccine.2020.06.062
   PubMed Web of Science ®Google Scholar
• Huang KW, Hsu FF, Qiu JT, et al. Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer. Sci Adv. 2020;6(3):eaax5032. doi:10.1126/sciadv.aax5032
   PubMed Web of Science ®Google Scholar
• Xu Z, Shen G, Xia X, et al. Comparisons of three polyethyleneimine-derived nanoparticles as a gene therapy delivery system for renal cell carcinoma. J Transl Med. 2011;9(1):46. doi:10.1186/1479-5876-9-46
   PubMedGoogle Scholar
• Bell GD, Yang Y, Leung E, Krissansen GW. mRNA transfection by a Xentry-protamine cell-penetrating peptide is enhanced by TLR antagonist E6446. PLoS One. 2018;13(7):e0201464. doi:10.1371/journal.pone.0201464
   PubMed Web of Science ®Google Scholar
• Duan X, Wang P, Men K, et al. Treating colon cancer with a suicide gene delivered by self-assembled cationic MPEG-PCL micelles. Nanoscale. 2012;4(7):2400–2407. doi:10.1039/c2nr30079f
   PubMed Web of Science ®Google Scholar
• Men K, Huang R, Zhang X, et al. Local and systemic delivery of interleukin-12 gene by cationic micelles for cancer immunogene therapy. J Biomed Nanotechnol. 2018;14(10):1719–1730. doi:10.1166/jbn.2018.2593
   PubMed Web of Science ®Google Scholar
• Guidotti G, Brambilla L, Rossi D. Cell-penetrating peptides: from basic research to clinics. Trends Pharmacol Sci. 2017;38(4):406–424. doi:10.1016/j.tips.2017.01.003
   PubMed Web of Science ®Google Scholar
• Vaissière A, Aldrian G, Konate K, et al. A retro-inverso cell-penetrating peptide for siRNA delivery. J Nanobiotechnology. 2017;15(1):34. doi:10.1186/s12951-017-0269-2
   PubMedGoogle Scholar
• Guo F, Fu Q, Zhou K, et al. Matrix metalloprotein-triggered, cell penetrating peptide-modified star-shaped nanoparticles for tumor targeting and cancer therapy. J Nanobiotechnology. 2020;18(1):48. doi:10.1186/s12951-020-00595-5
   PubMed Web of Science ®Google Scholar
• Chen L, Fang S, Xiao X, Zheng B, Zhao M. Single-stranded DNA assisted cell penetrating peptide-DNA conjugation strategy for intracellular imaging of nucleases. Anal Chem. 2016;88(23):11306–11309. doi:10.1021/acs.analchem.6b03743
   PubMedGoogle Scholar
• Song J, Huang S, Zhang Z, et al. SPA: a peptide antagonist that acts as a cell-penetrating peptide for drug delivery. Drug Deliv. 2020;27(1):91–99. doi:10.1080/10717544.2019.1706669
   PubMed Web of Science ®Google Scholar
• Gleeson FC, Levy MJ, Jackson RA, et al. Endoscopic ultrasound may be used to deliver gene expression signatures using digital mRNA detection methods to immunophenotype pancreatic ductal adenocarcinoma to facilitate personalized immunotherapy. Pancreatology. 2020;20(2):229–238. doi:10.1016/j.pan.2019.12.002
   PubMedGoogle Scholar
• Maruggi G, Zhang C, Li J, Ulmer JB, Yu D. mRNA as a transformative technology for vaccine development to control infectious diseases. Mol Ther. 2019;27(4):757–772. doi:10.1016/j.ymthe.2019.01.020
   PubMed Web of Science ®Google Scholar
• Sahu I, Haque A, Weidensee B, Weinmann P, Kormann MSD. Recent developments in mRNA-based protein supplementation therapy to target lung diseases. Mol Ther. 2019;27(4):803–823. doi:10.1016/j.ymthe.2019.02.019
   PubMed Web of Science ®Google Scholar
• Kowalski PS, Rudra A, Miao L, Anderson DG. Delivering the messenger: advances in technologies for therapeutic mRNA delivery. Mol Ther. 2019;27(4):710–728. doi:10.1016/j.ymthe.2019.02.012
   PubMed Web of Science ®Google Scholar
• Miao L, Li L, Huang Y, et al. Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation. Nat Biotechnol. 2019;37(10):1174–1185. doi:10.1038/s41587-019-0247-3
   PubMed Web of Science ®Google Scholar
• Capasso Palmiero U, Kaczmarek JC, Fenton OS, Anderson DG. Poly(β-amino ester)-co-poly(caprolactone) terpolymers as nonviral vectors for mrna delivery in vitro and in vivo. Adv Healthcare Mater. 2018;7(14):e1800249. doi:10.1002/adhm.201800249
   Google Scholar
• Hoerr I, Obst R, Rammensee HG, Jung G. In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies. Eur J Immunol. 2000;30(1):1–7. doi:10.1002/1521-4141(200001)30:1<1::aid-immu1>3.0.co;2-#
   PubMed Web of Science ®Google Scholar
• Choi HY, Lee TJ, Yang GM, et al. Efficient mRNA delivery with graphene oxide-polyethylenimine for generation of footprint-free human induced pluripotent stem cells. J Control Release. 2016;235:222–235. doi:10.1016/j.jconrel.2016.06.007
   PubMed Web of Science ®Google Scholar
• Huang X, Zheng R, Ding F, et al. Efficient delivery of mRNA using crosslinked nucleic acid nanogel as a carrier. ACS Mater Lett. 2020;2(11):1509–1515. doi:10.1021/acsmaterialslett.0c00375
   Google Scholar
• Cherukula K, Uthaman S, Park IK. Design of an amphiphilic poly(aspartamide)-mediated self-assembled nanoconstruct for long-term tumor targeting and bioimaging. Molecules. 2019;24(5):885. doi:10.3390/molecules24050885
   PubMed Web of Science ®Google Scholar
• Yu Y, Kim HJ, Mi P, et al. Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles. J Control Release. 2016;244(Pt B):247–256. doi:10.1016/j.jconrel.2016.08.041
   PubMedGoogle Scholar
• Martínez-Jothar L, Barendrecht AD, de Graaff AM, et al. Endothelial cell targeting by cRGD-functionalized polymeric nanoparticles under static and flow conditions. Nanomaterials. 2020;10(7):1353. doi:10.3390/nano10071353
   Google Scholar
• Islam MA, Xu Y, Tao W, et al. Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA. Nat Biomed Eng. 2018;2(11):850–864. doi:10.1038/s41551-018-0284-0
   PubMed Web of Science ®Google Scholar
• Lei S, Zhang X, Men K, et al. Efficient colorectal cancer gene therapy with IL-15 mRNA nanoformulation. Mol Pharm. 2020;17(9):3378–3391. doi:10.1021/acs.molpharmaceut.0c00451
   PubMedGoogle Scholar
• Pardi N, Tuyishime S, Muramatsu H, et al. Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes. J Control Release. 2015;217:345–351. doi:10.1016/j.jconrel.2015.08.007
   PubMed Web of Science ®Google Scholar